Please login to the form below

Not currently logged in
Email:
Password:

Pharming

This page shows the latest Pharming news and features for those working in and with pharma, biotech and healthcare.

EMA starts rapid review of Shire’s HAE antibody

EMA starts rapid review of Shire’s HAE antibody

Other approved treatments for HAE include CSL Behring’s Berinert and Pharming’s Ruconest.

Latest news

  • Opdivo backed for two new uses by CHMP Opdivo backed for two new uses by CHMP

    The CHMP also recommended extensions of indications for Boehringer Ingelheim's Giotrif (afatinib), Abbvie's Humira (adalimumab), Pharming's Ruconest (conestat alfa), Takeda's TachoSil (human thrombin/human fibrinogen) and

  • FDA approves drug for rare swelling diseases FDA approves drug for rare swelling diseases

    FDA approves drug for rare swelling diseases. Salix and Pharming’ s Ruconest is made from the milk of genetically-modified rabbits. ... Ruconest is developed in partnership by Salix Pharmaceutical and Pharming and is intended as a protein replacement

  • Trial delay prompts Pharming to look at "strategic alternatives"

    Trial delay prompts Pharming to look at "strategic alternatives". Dutch biotech awaits key milestone payment relating to its lead drug Ruconest. ... That filing - the second attempt by Pharming and Santarus after the FDA refused to accept an earlier

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    Finally it was interesting to see that Pharming has recovered from Valeant the North American rights to its product Ruconest. ... Pharming did well to get the rights back especially as it resulted in Valeant having to make a $199m write down of its

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics